Research view
Switch to patient viewAlzheimer disease: trials that stopped early
Trials on Alzheimer disease that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.
Stopped early
86 stopped trials give a reason in the registry, latest registry update first.
Withdrawn
Pre-Pilot: Problem Adaptation THerapy in Caregivers
Reason given in the registry “Study not started, investigators opted to focus on other projects.”
Quoted unchanged from ClinicalTrials.gov; record updated 31 Jan 2025.
- Ended
- Dec 2025
- Run by
- Weill Medical College of Cornell University
- Registry record
- NCT05567120
Withdrawn
Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study
Reason given in the registry “Not realisable on time planned and with the academic funds”
Quoted unchanged from ClinicalTrials.gov; record updated 27 Jan 2025.
- Ended
- Oct 2026
- Run by
- Erasme University Hospital
- Registry record
- NCT06391853
Terminated
Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease
Reason given in the registry “Due to the inability to complete subject enrollment and follow-up as originally scheduled, coupled with funding shortages and overall strategic adjustments from the sponsor, the study was terminated on November 12, 2024.”
Quoted unchanged from ClinicalTrials.gov; record updated 4 Dec 2024.
- Ended
- Nov 2024
- Phase
- Phase 2
- Run by
- Capital Medical University
- Registry record
- NCT05670912
Withdrawn
Voice and Swallowing Disorders in Adults With and Without Alzheimer's Disease
Reason given in the registry “Change of scope of the work given feedback from funding agency leading to new IRB/clinicaltrials.gov registration.”
Quoted unchanged from ClinicalTrials.gov; record updated 7 Nov 2024.
- Ended
- Nov 2024
- Run by
- Vanderbilt University Medical Center
- Registry record
- NCT06328374
Withdrawn
Meaningful Aspects of Health for Adults With Dementia, Their Care Partners and Healthcare Practitioners
Reason given in the registry “Submission to EC abandonned”
Quoted unchanged from ClinicalTrials.gov; record updated 19 Sept 2024.
- Ended
- Mar 2025
- Run by
- Centre Hospitalier Universitaire de Nice
- Registry record
- NCT06242574
Terminated
Biological Sample Collection for Research and Biobanking
Reason given in the registry “The study was voluntarily terminated by the PI to focus efforts on an alternative biobanking protocol.”
Quoted unchanged from ClinicalTrials.gov; record updated 2 Aug 2024.
- Ended
- Nov 2023
- Run by
- New York Stem Cell Foundation Research Institute
- Registry record
- NCT04270604
Terminated
Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome
Reason given in the registry “COVID delayed study timelines. Competing studies began enrolling at our sites.”
Quoted unchanged from ClinicalTrials.gov; record updated 27 Jun 2024.
- Ended
- Apr 2024
- Run by
- LuMind IDSC Foundation
- Registry record
- NCT04149197
Terminated
A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.
Reason given in the registry “Part I: Open-label was completed.”
Quoted unchanged from ClinicalTrials.gov; record updated 27 Jun 2024.
- Ended
- Mar 2024
- Run by
- M. H MediCane Ltd.
- Registry record
- NCT06217146
Terminated
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension
Reason given in the registry “Study only continued to 2 year follow-up.”
Quoted unchanged from ClinicalTrials.gov; record updated 14 Jun 2024.
- Ended
- Jun 2024
- Run by
- Novoic Limited
- Registry record
- NCT04846426
Terminated
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
Reason given in the registry “Study only continued to 2 year follow-up.”
Quoted unchanged from ClinicalTrials.gov; record updated 14 Jun 2024.
- Ended
- May 2024
- Run by
- Novoic Limited
- Registry record
- NCT04951284
Withdrawn
WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease
Reason given in the registry “funding purposes”
Quoted unchanged from ClinicalTrials.gov; record updated 13 May 2024.
- Ended
- Mar 2024
- Run by
- Scion NeuroStim
- Registry record
- NCT05032482
Terminated
PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand
Reason given in the registry “PI closed the protocol due to low recruitment”
Quoted unchanged from ClinicalTrials.gov; record updated 1 May 2024.
- Ended
- Dec 2023
- Phase
- Phase 1
- Run by
- National Institute of Mental Health (NIMH)
- Registry record
- NCT03958630
Terminated
Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease
Reason given in the registry “Insufficient Recruitment”
Quoted unchanged from ClinicalTrials.gov; record updated 10 Apr 2024.
- Ended
- Mar 2024
- Phase
- Phase 1
- Run by
- German Center for Neurodegenerative Diseases (DZNE)
- Registry record
- NCT03056495
Withdrawn
Intermittent Oral-esophageal Tube Feeding in Alzheimer's Patients With Dysphagia
Reason given in the registry “ethical issues”
Quoted unchanged from ClinicalTrials.gov; record updated 5 Mar 2024.
- Ended
- Aug 2024
- Run by
- Zeng Changhao
- Registry record
- NCT06220292
Terminated
Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD)
Reason given in the registry “The study was terminated after completing the dose escalation portion of the study. The expansion cohort was not initiated to conduct a global trial based on the approved US IND using a new manufacturing process.”
Quoted unchanged from ClinicalTrials.gov; record updated 1 Mar 2024.
- Ended
- Jan 2024
- Phase
- Phase 1
- Run by
- NKGen Biotech, Inc.
- Registry record
- NCT04678453
Withdrawn
Toolkit for Experiential Well-beiNg in Dementia (TEND)
Reason given in the registry “We are withdrawing our study due to regulatory requirements from our funding source.”
Quoted unchanged from ClinicalTrials.gov; record updated 22 Feb 2024.
- Ended
- Apr 2024
- Run by
- Massachusetts General Hospital
- Registry record
- NCT06257563
Withdrawn
Videoconferencing Acceptance and Commitment Therapy With a Web App Use for Family Caregivers of People With Dementia
Reason given in the registry “We changed our plan.”
Quoted unchanged from ClinicalTrials.gov; record updated 5 Jan 2024.
- Run by
- University of Alabama at Birmingham
- Registry record
- NCT05518968
Withdrawn
A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension
Reason given in the registry “Study replaced with a new study”
Quoted unchanged from ClinicalTrials.gov; record updated 14 Apr 2023.
- Ended
- Feb 2024
- Phase
- Phase 3
- Run by
- Cerecin
- Registry record
- NCT04187547
Withdrawn
Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior
Reason given in the registry “PI withdrawn”
Quoted unchanged from ClinicalTrials.gov; record updated 22 Mar 2023.
- Ended
- Oct 2024
- Run by
- Weill Medical College of Cornell University
- Registry record
- NCT03149380
Suspended
A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease
Reason given in the registry “The quality of study was seriously affected by the COVID-19, so it was decided to suspend the trial and restart it at the right time.”
Quoted unchanged from ClinicalTrials.gov; record updated 23 Nov 2022.
- Ended
- Oct 2026
- Phase
- Phase 3
- Run by
- Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
- Registry record
- NCT04520412
Withdrawn
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia
Reason given in the registry “Study withdrawn and being modified under another protocol”
Quoted unchanged from ClinicalTrials.gov; record updated 17 Nov 2022.
- Ended
- Dec 2024
- Run by
- Mayo Clinic
- Registry record
- NCT05497817
Withdrawn
Acupuncture Treatment for Improving Alzheimer's Dementia
Reason given in the registry “due to covid19 pandemic”
Quoted unchanged from ClinicalTrials.gov; record updated 12 Oct 2022.
- Run by
- N & S Neurology Center, A Medical Group, Inc
- Registry record
- NCT04064021
Withdrawn
Lymphatic System Health in Alzheimer's Disease
Reason given in the registry “Pending COVID-19 pandemic”
Quoted unchanged from ClinicalTrials.gov; record updated 28 Sept 2022.
- Ended
- Dec 2023
- Phase
- Phase 1
- Run by
- Neurological Associates of West Los Angeles
- Registry record
- NCT04205539
Withdrawn
A Study of ACI-24 in Adults With Down Syndrome
Reason given in the registry “decision to proceed with an optimized study design and optimized vaccine formulation”
Quoted unchanged from ClinicalTrials.gov; record updated 22 Oct 2021.
- Ended
- Oct 2024
- Phase
- Phase 2
- Run by
- AC Immune SA
- Registry record
- NCT04373616
Withdrawn
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease
Reason given in the registry “Funding ran out before study started, prior PI left institution.”
Quoted unchanged from ClinicalTrials.gov; record updated 16 Sept 2020.
- Ended
- Jul 2025
- Phase
- Phase 2
- Run by
- Palo Alto Veterans Institute for Research
- Registry record
- NCT02500784
Withdrawn
Biomarkers in Neurodegenerative Diseases
Reason given in the registry “Lack of regulatory approval”
Quoted unchanged from ClinicalTrials.gov; record updated 12 Nov 2019.
- Ended
- Oct 2025
- Run by
- University of Minnesota
- Registry record
- NCT04055532
Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.